Fulcrum Therapeutics
FULC
#8396
Rank
โ‚ฌ0.25 B
Marketcap
3,36ย โ‚ฌ
Share price
-0.54%
Change (1 day)
-65.69%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2026 (TTM): -1,04ย โ‚ฌ

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is -1,10ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,08ย โ‚ฌ a decrease over its 2024 EPS that were of -0,18ย โ‚ฌ.

EPS history for Fulcrum Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,04ย โ‚ฌ-3.14%
2025-1,08ย โ‚ฌ490%
2024-0,18ย โ‚ฌ-87.34%
2023-1,44ย โ‚ฌ-36.29%
2022-2,26ย โ‚ฌ8.3%
2021-2,09ย โ‚ฌ-18.51%
2020-2,56ย โ‚ฌ-31.36%
2019-3,73ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 11.57%๐Ÿ‡บ๐Ÿ‡ธ USA